Works from 2020
Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates upon an institutional review, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Abstract)
Phase II trial of carfilzomib plus irinotecan in patients with small-cell lung cancer who have progressed on prior platinum-based chemotherapy, Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al. (Article)
Post-remission treatment (Tx) patterns for patients (Pts) with newly diagnosed (ND) acute myeloid leukemia (AML) in the Connect® MDS/AML Disease Registry, Gail J. Roboz, Michael A. Thompson, and et al (Abstract)
Real world observational study using Clonoseq® next generation sequencing in hematologic malignancies: The 'Watch' Registry, Krish Patel, Neil Bailey, Michael A. Thompson, et al. (Abstract)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Michael A. Thompson, Sandra Tomany Korman, et al. (Abstract)
Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis, T M. Wise-Draper, A Desai, Michael A. Thompson, et al. (Article)
Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, et al. (Abstract)
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study, Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al. (Article)
Waging war on war metaphors in cancer and COVID-19, Jonathan M Marron, Don S Dizon, Banu Symington, et al. (Article)
Works from 2019
546 Tumor free resection margin better with surgical resection as opposed to endoscopic resection for esophageal T1b adenocarcinoma, Samit K. Datta, Geoffrey Bellini, Maharaj Singh, et al. (Abstract)
Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One, Michael A. Thompson, Jennifer J. Godden, Deborah Wham, Antony Ruggeri, Michael P. Mullane, Amanda Wilson, Shamsuddin Virani, Scott M. Weissman, Brenda Ramczyk, Pamela Vanderwall, and James L. Weese (Review)
Determining value of a precision medicine program in a vertically integrated healthcare system, James Weese, Michael A. Thompson, and Jennifer Godden (Oral/Podium Presentation)
Mo1412 – Oncologic outcomes of robotic compared to open pancreatic surgery: A national cancer database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Abstract)
Oncology precision medicine for hepatobiliary and pancreatic cancer: An institutional review, Geoffrey Bellini, Jennifer Godden, James Weese, et al. (Abstract)
p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression, Judy A. Tjoe, Brittany S. Last, and Jun Yin (Abstract)
Physiological and psychosocial effects of a highly structured exercise program on breast cancer survivorship, Judy A. Tjoe, Linda B Piacentine, Jun Yin, et al. (Abstract)
Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, et al. (Abstract)